• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

深度学习的二维超声放射组学预测乳腺癌新辅助化疗疗效。

Deep learning Radiomics Based on Two-Dimensional Ultrasound for Predicting the Efficacy of Neoadjuvant Chemotherapy in Breast Cancer.

机构信息

Jintan Peoples Hospital, Jiangsu, Changzhou, China.

Changzhou Second People's Hospital Affiliated to Nanjing Medical University, Jiangsu, Changzhou, China.

出版信息

Ultrason Imaging. 2024 Nov;46(6):357-366. doi: 10.1177/01617346241276168. Epub 2024 Sep 10.

DOI:10.1177/01617346241276168
PMID:39257175
Abstract

We investigate the predictive value of a comprehensive model based on preoperative ultrasound radiomics, deep learning, and clinical features for pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) for the breast cancer. We enrolled 155 patients with pathologically confirmed breast cancer who underwent NAC. The patients were randomly divided into the training set and the validation set in the ratio of 7:3. The deep learning and radiomics features of pre-treatment ultrasound images were extracted, and the random forest recursive elimination algorithm and the least absolute shrinkage and selection operator were used for feature screening and DL-Score and Rad-Score construction. According to multifactorial logistic regression, independent clinical predictors, DL-Score, and Rad-Score were selected to construct the comprehensive prediction model DLRC. The performance of the model was evaluated in terms of its predictive effect, and clinical practicability. Compared to the clinical, radiomics (Rad-Score), and deep learning (DL-Score) models, the DLRC accurately predicted the pCR status, with an area under the curve (AUC) of 0.937 (95%CI: 0.895-0.970) in the training set and 0.914 (95%CI: 0.838-0.973) in the validation set. Moreover, decision curve analysis confirmed that the DLRC had the highest clinical value among all models. The comprehensive model DLRC based on ultrasound radiomics, deep learning, and clinical features can effectively and accurately predict the pCR status of breast cancer after NAC, which is conducive to assisting clinical personalized diagnosis and treatment plan.

摘要

我们研究了一种基于术前超声放射组学、深度学习和临床特征的综合模型对新辅助化疗(NAC)后乳腺癌病理完全缓解(pCR)的预测价值。我们纳入了 155 名经病理证实的乳腺癌患者,这些患者均接受了 NAC。患者按 7:3 的比例随机分为训练集和验证集。提取预处理超声图像的深度学习和放射组学特征,采用随机森林递归消除算法和最小绝对收缩和选择算子进行特征筛选和 DL-Score 和 Rad-Score 构建。根据多因素逻辑回归,选择独立的临床预测因子、DL-Score 和 Rad-Score 构建综合预测模型 DLRC。根据预测效果和临床实用性评估模型性能。与临床、放射组学(Rad-Score)和深度学习(DL-Score)模型相比,DLRC 准确预测了 pCR 状态,在训练集和验证集的曲线下面积(AUC)分别为 0.937(95%CI:0.895-0.970)和 0.914(95%CI:0.838-0.973)。此外,决策曲线分析证实,DLRC 在所有模型中具有最高的临床价值。基于超声放射组学、深度学习和临床特征的综合模型 DLRC 可以有效准确地预测 NAC 后乳腺癌的 pCR 状态,有助于辅助临床制定个性化的诊断和治疗方案。

相似文献

1
Deep learning Radiomics Based on Two-Dimensional Ultrasound for Predicting the Efficacy of Neoadjuvant Chemotherapy in Breast Cancer.深度学习的二维超声放射组学预测乳腺癌新辅助化疗疗效。
Ultrason Imaging. 2024 Nov;46(6):357-366. doi: 10.1177/01617346241276168. Epub 2024 Sep 10.
2
Predicting the efficacy of neoadjuvant chemotherapy in breast cancer patients based on ultrasound longitudinal temporal depth network fusion model.基于超声纵向时间深度网络融合模型预测乳腺癌患者新辅助化疗的疗效
Breast Cancer Res. 2025 Feb 27;27(1):30. doi: 10.1186/s13058-025-01971-5.
3
Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer.基于超声的深度学习放射组学在局部晚期乳腺癌新辅助化疗病理完全缓解评估中的应用。
Eur J Cancer. 2021 Apr;147:95-105. doi: 10.1016/j.ejca.2021.01.028. Epub 2021 Feb 24.
4
Longitudinal ultrasound-based AI model predicts axillary lymph node response to neoadjuvant chemotherapy in breast cancer: a multicenter study.基于纵向超声的人工智能模型预测乳腺癌新辅助化疗腋窝淋巴结反应:一项多中心研究。
Eur Radiol. 2024 Nov;34(11):7080-7089. doi: 10.1007/s00330-024-10786-5. Epub 2024 May 10.
5
Machine learning for predicting neoadjuvant chemotherapy effectiveness using ultrasound radiomics features and routine clinical data of patients with breast cancer.利用超声影像组学特征和乳腺癌患者的常规临床数据进行机器学习以预测新辅助化疗疗效
Front Oncol. 2025 Jan 14;14:1485681. doi: 10.3389/fonc.2024.1485681. eCollection 2024.
6
Early and noninvasive prediction of response to neoadjuvant therapy for breast cancer via longitudinal ultrasound and MR deep learning: A multicentre study.通过纵向超声和磁共振深度学习对乳腺癌新辅助治疗反应进行早期无创预测:一项多中心研究
Acad Radiol. 2025 Mar;32(3):1264-1273. doi: 10.1016/j.acra.2024.10.033. Epub 2024 Nov 13.
7
Radiomics of Multimodal Ultrasound for Early Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.多模态超声的影像组学用于早期预测乳腺癌新辅助化疗后的病理完全缓解
Acad Radiol. 2025 Apr;32(4):1861-1873. doi: 10.1016/j.acra.2024.11.012. Epub 2024 Dec 16.
8
Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: A multicenter study.超声深度学习影像组学用于全面预测乳腺癌患者新辅助化疗后的肿瘤及腋窝淋巴结状态:一项多中心研究
Cancer. 2023 Feb 1;129(3):356-366. doi: 10.1002/cncr.34540. Epub 2022 Nov 19.
9
Pretreatment ultrasound-based deep learning radiomics model for the early prediction of pathologic response to neoadjuvant chemotherapy in breast cancer.基于治疗前超声的深度学习影像组学模型用于早期预测乳腺癌新辅助化疗的病理反应
Eur Radiol. 2023 Aug;33(8):5634-5644. doi: 10.1007/s00330-023-09555-7. Epub 2023 Mar 28.
10
Ultrasound-Based Deep Learning Radiomics Nomogram for Tumor and Axillary Lymph Node Status Prediction After Neoadjuvant Chemotherapy.基于超声的深度学习影像组学列线图用于新辅助化疗后肿瘤及腋窝淋巴结状态预测
Acad Radiol. 2025 Jan;32(1):12-23. doi: 10.1016/j.acra.2024.07.036. Epub 2024 Aug 24.

引用本文的文献

1
Multimodal deep learning for predicting neoadjuvant treatment outcomes in breast cancer: a systematic review.用于预测乳腺癌新辅助治疗结果的多模态深度学习:一项系统综述
Biol Direct. 2025 Jun 23;20(1):72. doi: 10.1186/s13062-025-00661-8.
2
Tumor Morphology for Prediction of Poor Responses Early in Neoadjuvant Chemotherapy for Breast Cancer: A Multicenter Retrospective Study.肿瘤形态学预测乳腺癌新辅助化疗早期不良反应的多中心回顾性研究。
Tomography. 2024 Nov 20;10(11):1832-1845. doi: 10.3390/tomography10110134.